FloraWorks

Milwaukie, United States Founded: 2019 • Age: 7 yrs
Developer and supplier of cannabinoid products

About FloraWorks

FloraWorks is a Healthcare company based in Milwaukie (United States) founded in 2019 by Alleh Lindquist and Michael Thale. FloraWorks has raised $1.5 million across 1 funding round from investors including Bonaventure Equity. Its chief executive is Alleh Lindquist. FloraWorks offers products and services including TruCBN, Formulation Kit, Wholesale Ingredients, and Retail Products. Its focus areas include HealthTech, Cannabis HealthTech, Cannabinoid Therapeutics and Diversified. Its legal entity is FloraWorks Holdings Inc. Its competitors include Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma and 4 more; 6 of its 9 listed competitors have raised funding.

Company details

Developer and supplier of cannabinoid products. The company focuses on the discovery and development of rare and novel cannabinoids for commercial and therapeutic applications. It offers CBD and CBG isolates.

  • Headquarters Milwaukie, United States
  • Founders Alleh Lindquist, Michael Thale
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website flora-works.com
  • Social LinkedIn X Facebook
  • Legal Name Floraworks Holdings Inc.
Key Metrics
  • Total Equity Funding
    $1.5M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.5M (USD), Series A

    Dec 2022

  • Investors

Products & Services of FloraWorks

FloraWorks offers a comprehensive portfolio of products and services, including TruCBN, Formulation Kit, Wholesale Ingredients, and Retail Products.

TruCBN
Sleep Aid

Clinically validated cannabinoid for improving sleep quality.

Formulation Kit
Research Tool

Kit for developing cannabinoid-based formulations.

Wholesale Ingredients
Supply Product

High-quality cannabinoids for industry use.

Retail Products
Consumer Goods

Cannabinoid products for direct health applications.

Funding Insights of FloraWorks

FloraWorks has successfully raised a total of $1.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.5 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.5M
  • Total Rounds 1
  • Last Round Series A β€” $1.5M
  • First Round $1.5M

    (Dec 2022)

  • Investors Count 1

All 1 funding rounds of FloraWorks with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2022$1.5MSeries A–Bonaventure Equity
–
Valuation history

1 investors in total: 1 institutional.

Investors in FloraWorks

FloraWorks has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bonaventure Equity.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–bvequity.com-
Premium access

Investor details for FloraWorks

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of FloraWorks

5 people are tracked at FloraWorks (4 in leadership, 1 in team).

NameRoleGroup
Alleh Lindquist
Co-Founder & CEOLeadership
Michael Thale
Co-FounderLeadership
Vaughn Hartung
Founder & Vice President of Science and TechnologyLeadership
Micah Hogan
Chief Growth OfficerLeadership
Arturo Bátiz
Sales AssociateTeam
Premium access

Complete people profiles for FloraWorks

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of FloraWorks

2 dated milestones of FloraWorks across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded FloraWorks is founded.
  2. Funding First funding round of $1.5M.

Competitors of FloraWorks

FloraWorks has 9 listed competitors in our database, 6 of them funded. They include Sanity Group, ZYUS Life Sciences, Terraflos, Avicanna and Tetra Bio-Pharma, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sanitygroup.com2011Berlin, Germany$108.79M–
Developer of cannabinoid-based pharmaceuticals and well-being products
zyus.com2018Saskatoon, Canada$19.5M–
Cannabis-derived therapeutics for multiple indications are developed.
terraflos.com2021Uruguay$8M–
Medical cannabis products are provided based on GMP processes.
avicanna.com2016Toronto, Canada$5.94M–
Plant-derived cannabinoid products are developed for medical and consumer uses.
tetrabiopharma.com2015Ottawa, Canada––
Natural medicinal plant-based elements are developed for treating multiple diseases.
littlegreenpharma.com2016Perth, Australia$1.91M–
Manufacturer of medicinal cannabis for therapeutic use
kalytera.co2014San Rafael, United States––
Cannabinoid therapies for osteoporosis and bone healing are developed.
cresopharma.com2015Perth, Australia––
Cannabinoid therapeutics are developed for human and veterinary health applications.
boheco.com2013Mumbai, India$9.53M41
Cannabis-derived nutritional and wellness products are provided online.
Premium access

Detailed competitors of FloraWorks

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of FloraWorks

The website of FloraWorks (flora-works.com) receives about 2.4K visits a month.

  • Monthly visits
    2.4K

    ▼ 20.5% vs previous month

Top companies in Cannabis Health Tech Ecosystem

10 companies that operate in the same segment as FloraWorks (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cannabis products are provided to support consumer wellness and health.
2013Smiths Falls, Ontario, Canada–USD 204.24 M960
Online marketplace platform for cannabis traders
2015New York, New York, United StatesUSD 195.4 M––
Loyalty and marketing solutions for cannabis dispensaries are provided.
2012West Palm Beach, Florida, United StatesUSD 25.79 MUSD 22.83 M–
An online marketplace for cannabis products is operated.
2017Bend, Oregon, United StatesUSD 603 M–469
Online platform for cannabis strains, reviews, and ratings
2010Seattle, Washington, United StatesUSD 40.7 M––
Provider of cannabis products, brands, and international business development investments
2013Moncton, New Brunswick, Canada–USD 186.16 M898
ERP software is offered via cloud platform for cannabis operations.
2018Boston, Massachusetts, United States–USD 110.08 M313
Online marketplace connecting licensed cannabis vendors and dispensaries
2015Chicago, Illinois, United StatesUSD 22.57 M––
Enterprise software is provided for cannabis dispensary management.
2016Oakland, California, United StatesUSD 75.5 MUSD 148.97 K97
Proprietary medical cannabis strains are developed and offered.
2014Maryland Heights, Missouri, United StatesUSD 156 M–557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Floraworks

Premium access

Complete news archive for FloraWorks

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FloraWorks

FloraWorks was founded in 2019 and raised its 1st funding round 3 years after it was founded.

FloraWorks is headquartered in Milwaukie, United States. It is registered at Milwaukie, Oregon, United States.

Alleh Lindquist is the current CEO of FloraWorks. They have also founded this company.

FloraWorks is a funded company, having raised a total of $1.5M across 1 funding round to date. The company's 1st funding round was a Series A of $1.5M, raised on Dec 2022.

Developer and supplier of cannabinoid products. The company focuses on the discovery and development of rare and novel cannabinoids for commercial and therapeutic applications. It offers CBD and CBG isolates.

FloraWorks's top competitors include Avicanna, ZYUS Life Sciences and Sanity Group.

FloraWorks offers TruCBN, Formulation Kit, Wholesale Ingredients, and Retail Products.

FloraWorks has 1 investor. Key investors include Bonaventure Equity.

FloraWorks operates through Floraworks Holdings Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available